Polyclonal Rabbit anti‑Mouse PEX1 Antibody (APC,Cy7, aa172‑377, WB) LS‑C734854
Polyclonal Rabbit anti‑Mouse PEX1 Antibody (APC,Cy7, aa172‑377, WB) LS‑C734854
Antibody:
PEX1 Rabbit anti-Mouse Polyclonal (aa172-377) (APC, Cy7) Antibody
Format:
Allophycocyanin, Cy7, Unmodified
Overview
Antibody:
PEX1 Rabbit anti-Mouse Polyclonal (aa172-377) (APC, Cy7) Antibody
Format:
Allophycocyanin, Cy7, Unmodified
Specifications
Description
PEX1 antibody LS-C734854 is an APC, Cy7-conjugated rabbit polyclonal antibody to mouse PEX1 (aa172-377). Validated for WB.
Target
Mouse PEX1
Synonyms
PEX1 | PBD1A | PBD1B | Peroxisome biogenesis factor 1 | ZWS | ZWS1 | Zellweger syndrome 1 | Peroxin-1 | Peroxisome biogenesis gene 1 | Zellweger syndrome
Reactivity
Mouse
(tested or 100% immunogen sequence identity)
Conjugations
Allophycocyanin, Cy7.
Also available
Unconjugated or conjugated with
Biotin,
FITC,
Cy3,
HRP,
APC,
PE.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant PEX1 (Asn172-Ala377)
Specificity
The antibody is a rabbit polyclonal antibody raised against PEX1.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse
Applications:
Western blot, Immunoprecipitation
Species:
Human
Applications:
Western blot
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot
Reactivity:
Rat
Range:
1.25-80 ng/ml
Source:
Human
Tag:
DDK (Flag)
Reactivity:
Rat
Range:
0.312-20 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/29/2024